| 1 |
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 775-787.
|
| 2 |
王伊帆, 陈燕, 彭劲民, 等. 中国脓毒症流行病学的研究进展 [J/OL]. 中华重症医学电子杂志, 2023, 9(1): 89-94.
|
| 3 |
Cohen J. The immunopathogenesis of sepsis [J]. Nature, 2002, 420(6917): 885-891.
|
| 4 |
Goodman S, Weiss Y, Weissman C. Update on cardiac arrhythmias in the ICU [J]. Curr Opin Crit Care, 2008, 14(5): 549-554.
|
| 5 |
Angus DC, Van Der Poll T. Severe sepsis and septic shock [J]. N Engl J Med, 2013, 369(9): 840-851.
|
| 6 |
Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation [J]. Nat Rev Cardiol, 2015, 12(4): 230-243.
|
| 7 |
Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation [J]. Circulation, 2003, 108(24): 3006-3010.
|
| 8 |
Andrade J, Khairy P, Dobrev D, et al. The clinical profile and pathophysiology of atrial fibrillation [J]. Circ Res, 2014, 114(9): 1453-1468.
|
| 9 |
Madhavan M, Graff-Radford J, Piccini JP, et al. Cognitive dysfunction in atrial fibrillation [J]. Nat Rev Cardiol, 2018, 15(12): 744-756.
|
| 10 |
Chung MK, Refaat M, Shen WK, et al. Atrial fibrillation: JACC Council Perspectives [J]. J Am Coll Cardiol, 2020, 75(14): 1689-1713.
|
| 11 |
Walkey AJ, Wiener RS, Ghobrial JM, et al. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis [J]. JAMA, 2011, 306(20): 2248-2254.
|
| 12 |
Walkey AJ, Myers LC, Thai KK, et al. Practice patterns and outcomes associated with anticoagulation use following sepsis hospitalizations with new-onset atrial fibrillation [J]. Circ Cardiovasc Qual Outcomes, 2023, 16(3): E009494.
|
| 13 |
Bosch N A, Cimini J, Walkey A J. Atrial Fibrillation in the ICU [J]. Chest, 2018, 154(6): 1424-1434.
|
| 14 |
Meierhenrich R, Steinhilber E, Eggermann C, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study [J]. Crit Care, 2010, 14(3): R108.
|
| 15 |
Kuipers S, Klein Klouwenberg PM, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review [J]. Crit Care, 2014, 18(6): 688.
|
| 16 |
Fernando SM, Mathew R, Hibbert B, et al. New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study [J]. Crit Care, 2020, 24(1): 15.
|
| 17 |
Gandhi S, Litt D, Narula N. New-onset atrial fibrillation in sepsis is associated with increased morbidity and mortality [J]. Neth Heart J, 2015, 23(2): 82-88.
|
| 18 |
Walkey AJ, Hammill BG, Curtis LH, et al. Long-term outcomes following development of new-onset atrial fibrillation during sepsis [J]. Chest, 2014, 146(5): 1187-1195.
|
| 19 |
Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J]. Circulation, 2024, 149(1): e1-e156.
|
| 20 |
Darwish OS, Strube S, Nguyen HM, et al. Challenges of anticoagulation for atrial fibrillation in patients with severe sepsis [J]. Ann Pharmacother, 2013, 47(10): 1266-1271.
|
| 21 |
Corica B, Romiti GF, Basili S, et al. Prevalence of new-onset atrial fibrillation and associated outcomes in patients with sepsis: a systematic review and Meta-analysis [J]. J Pers Med, 2022, 12(4): 547.
|
| 22 |
Desai R, Hanna B, Singh S, et al. Trends and outcomes in sepsis hospitalizations with and without atrial fibrillation: a nationwide inpatient analysis [J]. Crit Care Med, 2019, 47(8): e630-e638.
|
| 23 |
Lubitz SA, Yin X, Rienstra M, et al. Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study [J]. Circulation, 2015, 131(19): 1648-1655.
|
| 24 |
Arunachalam K, Kalyan Sundaram A, Jha K, et al. Evaluation of anticoagulation practice with new-onset atrial fibrillation in patients with sepsis and septic shock in medical intensive care unit: a retrospective observational cohort study [J]. Cureus, 2020, 12(8): e10026.
|
| 25 |
Wang EY, Hulme OL, Khurshid S, et al. Initial precipitants and recurrence of atrial fibrillation [J]. Circ Arrhythm Electrophysiol, 2020, 13(3): e007716.
|
| 26 |
Chyou JY, Barkoudah E, Dukes JW, et al. Atrial fibrillation occurring during acute hospitalization: a scientific statement from the American Heart Association [J]. Circulation, 2023, 147(15): e676-e698.
|
| 27 |
中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南 [J]. 中华心血管病杂志, 2023, 51(6): 572-618.
|
| 28 |
Chean CS, Mcauley D, Gordon A, et al. Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey [J]. PeerJ, 2017, 5: e3716.
|
| 29 |
Ko D, Saleeba C, Sadiq H, et al. Secondary precipitants of atrial fibrillation and anticoagulation therapy [J]. J Am Heart Assoc, 2021, 10(21): e021746.
|
| 30 |
Myers LC, Peltan I D, Thai KK, et al. Predicting stroke risk after sepsis hospitalization with new-onset atrial fibrillation [J]. J Hosp Med, 2024, 19(7): 565-571.
|
| 31 |
Walkey AJ, Quinn EK, Winter MR, et al. Practice patterns and outcomes associated with use of anticoagulation among patients with atrial fibrillation during sepsis [J]. JAMA Cardiol, 2016, 1(6): 682-690.
|
| 32 |
Quon MJ, Behlouli H, Pilote L. Anticoagulant use and risk of ischemic stroke and bleeding in patients with secondary atrial fibrillation associated with acute coronary syndromes, acute pulmonary disease, or sepsis [J]. JACC Clin Electrophysiol, 2018, 4(3): 386-393.
|
| 33 |
Ge G, Bo D, Jiang R, et al. Oral anticoagulants increased 30-day survival in sepsis patients complicated with atrial fibrillation: a retrospective analysis from MIMIC-Ⅳ database [J]. Front Cardiovasc Med, 2024, 11: 1322045.
|
| 34 |
Induruwa I, Hennebry E, Hennebry J, et al. Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation? [J]. Eur J Intern Med, 2022, 98: 32-36.
|
| 35 |
Li YG, Lip GYH. Stroke prevention in atrial fibrillation: State of the art [J]. Int J Cardiol, 2019, 287: 201-209.
|
| 36 |
Agarwal S, Hachamovitch R, Menon V. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis [J]. Arch Intern Med, 2012, 172(8): 623-631; discussion 631-633.
|